Drug Database · Clinicians

Recombinant + Respiratory syncytial virus vaccine bivalent

Brands (1) AbrysvoShow all

Vaccine PH FDA category
Fixed-dose combination.

Rx · Prescription drug2 PH products
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals
US label not yet available for this generic. Check the Philippine package insert (linked in the products table where the FDA has published one).

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Registered products in the Philippines

2 products registered with the Food and Drug Administration (FDA) Philippines list Recombinant + Respiratory syncytial virus vaccine bivalent as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

Philippine FDA-registered products for Recombinant + Respiratory syncytial virus vaccine bivalent
Package insert
AbrysvoRespiratory Syncytial Virus Vaccine (Bivalent, Recombinant)
Formulation: After reconstitution, 0.5mL (one dose) contains: RSV subgroup A stabilized prefusion F antigen 1.2 60 micrograms RSV subgroup B stabilized prefusion F antigen 1.2 60 micrograms (RSV antigens) 1 glycoprotein F stabilized in the prefusion conformation 2 produced in Chinese Hamster Ovary cells by recombinant DNA technology. Lyophilized Powder and Solvent for Solution for Intramuscular Injection(1) 2 mL type I borosilicate glass vial with 13 mm vial stopper and aluminum vial seal with tamper-evident polypropylene flip off cap [vaccine] + (1) 1 mL pre-filled syringe type I borosilicate glass with plastic Luer lock adapter and a synthetic isoprene bromobutyl rubber tip cap with a plastic rigid tip cap cover and chlorobutyl rubber plunger stopper [water for injection (solvent)] + (1) 13 mm vial adapter + (1) 25G needle [Box of 1's]
Rx
Pfizer Manufacturing Belgium NVBelgium
Importer: Pfizer, Inc.
BR-1489
Sep 18, 2029
AbrysvoRespiratory Syncytial Virus Vaccine (bivalent, recombinant)
Formulation: After reconstitution, 0.5mL (one dose) contains: RSV subgroup A stabilized prefusion F antigen 1.2 60 micrograms RSV subgroup B stabilized prefusion F antigen 1.2 60 micrograms (RSV antigens) glycoprotein F stabilized in the prefusion conformation produced in Chinese Hamster Ovary cells by recombinant DNA technology. Lyophilized Powder and Solvent for Solution for Intramuscular Injection(1) 2 mL type I aluminosilicate glass vial with 13 mm vial stopper and aluminum vial seal with tamper-evident polypropylene flip off cap [vaccine] + (1) 1 mL pre-filled syringe type I borosilicate glass with plastic Luer lock adapter and a synthetic isoprene bromobutyl rubber tip cap with a plastic rigid tip cap cover and chlorobutyl rubber plunger stopper [water for injection (solvent)] + (1) 13 mm vial adapter +(1) 25G needle [Box of 1's]
Rx
Pfizer Manufacturing Belgium NVBelgium
Importer: Pfizer, Inc.
BR-1488
Sep 18, 2029

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .